Neurobehavioral outcomes in diseases of childhood. Individual change models for pediatric human immunodeficiency viruses.

The growing incidence of human immunodeficiency virus-1 (HIV-1) and acquired immunodeficiency syndrome (AIDS) in children is a major public health problem. Current research emphasizes treatments for ameliorating deleterious effects on the child's neurological and behavioral development. This article outlines approaches to the assessment of individual change that may provide alternatives to more traditional approaches to the assessment of neurobehavioral outcomes in children with chronic diseases. These approaches provide more precise conceptualizations of changes that lead directly to statistical designs and measurement strategies for assessing effects of HIV-1 and AIDS on development. Such assessments can be superimposed on current clinical trial methodologies to evaluate the efficacy of pharmacological and behavioral interventions designed to improve quality of life in HIV-1 infected children.

[1]  M. Kline,et al.  Pediatric AIDS and HIV Infection: Fetus to Adolescent , 1992 .

[2]  N M Thompson,et al.  Analysis of change: modeling individual growth. , 1991, Journal of consulting and clinical psychology.

[3]  M. Appelbaum,et al.  Estimating Individual Developmental Functions: Methods and Their Assumptions , 1991 .

[4]  A. Belman.  AIDS and pediatric neurology. , 1990, Neurologic clinics.

[5]  P. Wise,et al.  Final report of the United States Department of Health and Human Services Secretary's Work Group on pediatric human immunodeficiency virus infection and disease: content and implications. , 1989, Pediatrics.

[6]  F. Schmitt,et al.  Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. , 1988, The New England journal of medicine.

[7]  D. Rubin,et al.  Statistical Analysis with Missing Data. , 1989 .

[8]  H. Minkoff,et al.  Serosurvey of human immunodeficiency virus infection in parturients: Implications for human immunodeficiency virus testing programs of pregnant women , 1987, JAMA.

[9]  Harvey Goldstein,et al.  Multilevel Models in Education and Social Research , 1987 .

[10]  J. Fleiss.  The design and analysis of clinical experiments , 1987 .

[11]  L. Epstein,et al.  Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy , 1987, Annals of neurology.

[12]  Stephen L. George,et al.  Fundamentals of Clinical Trials. (2nd ed.). , 1987 .

[13]  L. Hedges,et al.  Statistical Methods for Meta-Analysis , 1987 .

[14]  John B. Willett,et al.  Understanding correlates of change by modeling individual differences in growth , 1985 .

[15]  A. Siegel,et al.  Developmental Analysis: A Strategy for the Study of Psychological Change , 1983 .

[16]  H. Weisberg,et al.  Empirical Bayes estimation of individual growth-curve parameters and their relationship to covariates. , 1983, Biometrics.

[17]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[18]  David Rogosa,et al.  A growth curve approach to the measurement of change. , 1982 .

[19]  Anthony S. Bryk,et al.  Use of the nonequivalent control group design when subjects are growing. , 1977 .

[20]  C. Harris.  Problems in measuring change , 1965 .

[21]  R. C. Elston,et al.  Estimation of Time-Response Curves and Their Confidence Bands , 1962 .

[22]  A. Benton.  BEHAVIORAL INDICES OF BRAIN INJURY IN SCHOOL CHILDREN1,2 , 1962 .

[23]  D. Dickson,et al.  Pediatric acquired immunodeficiency syndrome. Neurologic syndromes. , 1988, American journal of diseases of children.

[24]  John B. Willett,et al.  Questions and Answers in the Measurement of Change , 1988 .

[25]  D. Routh.  Handbook of pediatric psychology , 1988 .

[26]  E. Cho,et al.  Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host , 1988, Annals of neurology.

[27]  S. Raudenbush,et al.  Application of Hierarchical Linear Models to Assessing Change , 1987 .

[28]  D. DeMets,et al.  Fundamentals of Clinical Trials , 1982 .